RocksonSG. The physiology of lymphatic pump therapeutics. Lymphat Res Biol., 2010; 8:141.
2.
PrajapatiP, ShahP, KingHH, WilliamsAGJr., DesaiP, DowneyHF. Lymphatic pump treatment increases thoracic duct lymph flow in conscious dogs with edema due to constriction of the inferior vena cava. Lymphat Res Biol., 2010; 8:149–154.
3.
SzubaA, AchaluR, RocksonSG. Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema. A randomized, prospective study of a role for adjunctive intermittent pneumatic compression. Cancer., 2002; 95:2260–2267.
4.
WilburnO, WilburnP, RocksonSG. A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412]BMC Cancer., 2006; 6:84.
5.
FoeldiE, FoeldiM, ClodiusI. The lymphedema chaos: A lancet. Ann Plast Surg., 1989; 22:505–515.
6.
Casley-SmithJR. Modern treatment of lymphoedema. I. Complex physical therapy: the first 200 Australian limbs. Australas J Dermatol., 1992; 33:61–68.
7.
BorisM, WeindorfS, LasinskiBB. The risk of genital edema after external pump compression for lower limb lymphedema. Lymphology., 1998; 31:15–20.
8.
HuffJ, SchanderA, DowneyH, HodgeL. Lymphatic pump treatment augments lymphatic flux of lymphocytes in rats. Lymphat Res Biol., 2010; 8:183–187.
9.
RidnerS, MurphyB, DengJ, KiddN, GalfordE, DietrichM. Advanced pneumatic therapy in self-care of chronic lymphedema of the trunk. Lymphat Res Biol., 2010; 8:209–215.
10.
BosompraK, AshikagaT, O'BrienPJ, NelsonL, SkellyJ. Swelling, numbness, pain, and their relationship to arm function among breast cancer survivors: a disablement process model perspective. Breast J., 2002; 8:338–348.
11.
RonkaRH, PamiloMS, von SmittenKA, LeideniusMH. Breast lymphedema after breast conserving treatment. Acta Oncol., 2004; 43:551–557.
12.
WilliamsAF, MoffattCJ, FranksPJ. A phenomenological study of the lived experiences of people with lymphoedema. Int J Palliat Nurs., 2004; 10:279–286.
13.
KarkiA, SimonenR, MalkiaE, SelfeJ. Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation. J Rehabil Med., 2005; 37:180–188.
